Not a good buy right now: trend is still bearish (SMA_200 > SMA_20 > SMA_5) and price is below the pivot (5.99), suggesting overhead resistance.
While MACD is modestly improving, the company’s latest quarter shows weakening profitability (net loss, EPS down, gross margin sharply down), which reduces near-term upside conviction.
With no news/catalysts, no meaningful institutional/insider momentum, and no proprietary buy signals today, the risk/reward is not attractive for an impatient buyer today.
Technical Analysis
Trend: Bearish structure with moving averages stacked negatively (SMA_200 > SMA_20 > SMA_5), implying the broader trend is down.
Momentum: MACD histogram is slightly positive (0.00362) and expanding, hinting at a potential early stabilization/turn attempt, but not confirmed by trend.
RSI(6): 35.947 (neutral-to-weak). It’s not deeply oversold, so there’s limited “snap-back” edge based on RSI alone.
Key levels: Pivot 5.99 overhead; near-term resistance at 6.27 then 6.45. Support at 5.705 then 5.53. With post-market ~5.86, price is still under pivot—more consistent with “sell/avoid rallies” than “buy breakouts.”
Pattern-based odds: Similar-pattern stats suggest modest upside potential (next day +1.71%, next week +4.26%), but this is fighting the prevailing bearish MA trend.
Intellectia Proprietary Trading Signals: AI Stock Pick: no signal on given stock today. SwingMax: No signal on given stock recently.
Positive Catalysts
Revenue growth in 2025/Q3: +13.33% YoY (top-line demand/revenue expansion).
MACD turning slightly positive and expanding could indicate early momentum improvement.
No notable hedge fund or insider selling pressure reported recently (both neutral).
Neutral/Negative Catalysts
and EPS fell to -0.
Gross margin dropped sharply to 23.91 (down -41.50% YoY), a major negative signal for operating quality.
Financial Performance
Latest quarter: 2025/Q3.
Revenue: 10,556,291 (+13.33% YoY) — growth is positive.
Net income: -503,358 (down -182.27% YoY) — profitability meaningfully worsened.
Gross margin: 23.91 (down -41.50% YoY) — margin compression is the key issue and weighs on valuation/recovery potential.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating or price target change data provided.
Wall Street-style pro view (based on available data): top-line growth could support a turnaround if margins normalize.
Wall Street-style con view (based on available data): steep gross-margin decline and a swing to losses reduce confidence; without clear catalysts, it’s hard to justify buying into a bearish trend today.
Wall Street analysts forecast FSI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for FSI is 11 USD with a low forecast of 11 USD and a high forecast of 11 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast FSI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for FSI is 11 USD with a low forecast of 11 USD and a high forecast of 11 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 5.520
Low
11
Averages
11
High
11
Current: 5.520
Low
11
Averages
11
High
11
Greenridge
NULL -> Buy
maintain
$9 -> $11
AI Analysis
2025-08-18
Reason
Greenridge
Price Target
$9 -> $11
AI Analysis
2025-08-18
maintain
NULL -> Buy
Reason
Greenridge raised the firm's price target on Flexible Solutions to $11 from $9 and keeps a Buy rating on the shares. The company's second food contract is a "significant win" that will drive earnings growth in the coming quarters and lead to possibly more deals, the analyst tells investors in a research note.
